TTI1
Basic information
Region (hg38): 20:37983007-38033461
Previous symbols: [ "KIAA0406" ]
Links
Phenotypes
GenCC
Source: 
- microcephaly (Limited), mode of inheritance: AR
- neurodevelopmental disorder with microcephaly and movement abnormalities (Strong), mode of inheritance: AR
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Neurodevelopmental disorder with microcephaly and movement abnormalities | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 36724785 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- Inborn_genetic_diseases (165 variants)
- not_provided (33 variants)
- Neurodevelopmental_disorder_with_microcephaly_and_movement_abnormalities (8 variants)
- not_specified (5 variants)
- Intellectual_disability,_severe (2 variants)
- Abnormal_brain_morphology (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TTI1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001303457.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 10 | 13 | ||||
| missense | 173 | 188 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 5 | 5 | 177 | 17 | 3 | 
Highest pathogenic variant AF is 0.000078072626
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| TTI1 | protein_coding | protein_coding | ENST00000373448 | 7 | 50462 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 4.90e-10 | 0.988 | 125681 | 0 | 67 | 125748 | 0.000266 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.220 | 545 | 560 | 0.974 | 0.0000306 | 7075 | 
| Missense in Polyphen | 132 | 146.41 | 0.90156 | 1854 | ||
| Synonymous | -0.720 | 236 | 222 | 1.06 | 0.0000118 | 2223 | 
| Loss of Function | 2.42 | 21 | 36.9 | 0.570 | 0.00000185 | 485 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000264 | 0.000264 | 
| Ashkenazi Jewish | 0.00120 | 0.00119 | 
| East Asian | 0.000489 | 0.000489 | 
| Finnish | 0.0000937 | 0.0000924 | 
| European (Non-Finnish) | 0.000231 | 0.000229 | 
| Middle Eastern | 0.000489 | 0.000489 | 
| South Asian | 0.000229 | 0.000229 | 
| Other | 0.000490 | 0.000489 | 
dbNSFP
Source: 
- Function
- FUNCTION: Regulator of the DNA damage response (DDR). Part of the TTT complex that is required to stabilize protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex is involved in the cellular resistance to DNA damage stresses, like ionizing radiation (IR), ultraviolet (UV) and mitomycin C (MMC). Together with the TTT complex and HSP90 may participate in the proper folding of newly synthesized PIKKs. Promotes assembly, stabilizes and maintains the activity of mTORC1 and mTORC2 complexes, which regulate cell growth and survival in response to nutrient and hormonal signals. {ECO:0000269|PubMed:20427287, ECO:0000269|PubMed:20801936, ECO:0000269|PubMed:20810650}.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human);Steatosis AOP (Consensus) 
Recessive Scores
- pRec
- 0.0939
Intolerance Scores
- loftool
- rvis_EVS
- -0.52
- rvis_percentile_EVS
- 20.94
Haploinsufficiency Scores
- pHI
- 0.187
- hipred
- Y
- hipred_score
- 0.577
- ghis
- 0.586
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Tti1
- Phenotype
Gene ontology
- Biological process
- regulation of TOR signaling
- Cellular component
- cytoplasm;TORC1 complex;TORC2 complex
- Molecular function
- protein binding